SEC Form 4 · accession 0001209191-15-079663
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Operating Officer
Period of report
Nov 10, 2015
Accepted (ET)
Nov 12, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2015 | M | 11,000 | $2.09 | A | 11,000 | D | |
| Common StockF2 | Nov 10, 2015 | S | 11,000 | $74.6045 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $2.09 | Nov 10, 2015 | M | 11,000 | D | — | Jul 13, 2021 | Common Stock | 11,000 | 18,513 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- F2The range of prices for the transaction reported on this line was $73.8650 to $74.7900. The average weighted price was $74.6045. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.